secwatch / observer
8-K filed June 17, 2026, 5:13 PM ET ticker VTGN CIK 0001411685
leadership confidence high sentiment neutral materiality 0.40

Two Vistagen directors will not stand for re-election at 2026 Annual Meeting

Vistagen Therapeutics, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joanne Curley

Director
VTGN · Vistagen Therapeutics, Inc.
Filed
June 17, 2026, 5:13 PM ET
On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
Departed

Margaret FitzPatrick

Director
VTGN · Vistagen Therapeutics, Inc.
Filed
June 17, 2026, 5:13 PM ET
On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joanne Curley departed as Director at Vistagen Therapeutics, Inc..

Action
not stand for re-election
Role
Director
Exact text from the filing
On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Margaret FitzPatrick departed as Director at Vistagen Therapeutics, Inc..

Action
not stand for re-election
Role
Director
Exact text from the filing
On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
View on SEC.gov

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001628280-26-043989
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.